Archive · 23 Jan 2026
IIT Bombay Develops AI Platforms for Brain Disease Research
Scientists at IIT Bombay have created two smart platforms, BrainProt and DrugProtAI, to help study brain diseases.
BrainProt is a big database that combines different types of biological information about the brain, like genes and proteins, to understand how the brain works in healthy and sick people.
It includes data from over 1,800 patient samples and covers 56 different brain diseases.
DrugProtAI is a tool that helps researchers figure out if a protein can be used to make a drug before spending a lot of time and money on experiments.
It gives a score that shows how likely a protein is to be useful for making a drug.
Together, these platforms help researchers quickly go from finding a disease marker to checking its patterns and seeing if it can be used to make a drug, all in about an hour.
IIT Bombay developed BrainProt v3.0 and DrugProtAI to unify data on brain diseases and identify druggable targets.
BrainProt integrates multi-disease data from genomics, transcriptomics, proteomics, and biomarker research into one platform.
The platform includes data on 56 human brain diseases and 52 multi-omics datasets from over 1,800 patient samples.
DrugProtAI predicts the druggability of proteins by analyzing their characteristics beyond sequence, generating a druggability index.
The integrated platforms allow researchers to move from identifying disease markers to evaluating druggability within an hour.
- Who
- Researchers at IIT Bombay, led by Prof. Sanjeeva Srivastava and Dr. Ankit Halder
- What
- Developed AI-integrated platforms BrainProt v3.0 and DrugProtAI for brain disease research
- When
- Not specified
- Where
- Indian Institute of Technology (IIT) Bombay
- Why
- To unify scattered data on brain diseases, identify markers, explore treatments, and pinpoint druggable targets
- Institutions
- Indian Institute of Technology (IIT) Bombay
- Platforms Developed
- BrainProt v3.0 and DrugProtAI
- Data Types Integrated
- Genomics, transcriptomics, proteomics, and biomarker research
- Diseases Covered
- 56 human brain diseases
- Patient Samples
- More than 1,800
- Druggability Index
- Probability score indicating protein druggability
- Key Researchers
- Prof. Sanjeeva Srivastava, Dr. Ankit Halder